Drug Type Recombinant polypeptide |
Synonyms- |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Diseases | Discovery | - | I2o Therapeutics, Inc.Startup | 23 Jun 2022 |
Liver Diseases | Discovery | - | 23 Jun 2022 | |
Nutritional and Metabolic Diseases | Discovery | - | I2o Therapeutics, Inc.Startup | 23 Jun 2022 |
Nutritional and Metabolic Diseases | Discovery | - | 23 Jun 2022 | |
Tauopathies | Discovery | - | I2o Therapeutics, Inc.Startup | 23 Jun 2022 |
Tauopathies | Discovery | - | 23 Jun 2022 |